• SENSEX 73,257.62
    -341.05 (--0.46%)
  • BANKNIFTY 53,974.90
    -391.80 (--0.72%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,160.50 1,152.30(%)
  • Piramal Pharma
    235.45 231.85(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    189.95 227.00(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • Cholaman.Inv.&Fn
    1,555.00 1,952.00(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • Acutaas Chemical
    3,690.00 1,571.20(%)
  • One 97
    1,640.50 1,856.50(%)
  • Ola Electric
    37.44 51.84(%)
  • Sahajanand Medi
    478.00 347.50(%)
  • Swiggy
    183.05 174.30(%)
  • Bajaj Finance
    918.00 1,177.60(%)
  • Infosys
    1,103.50 980.30(%)
  • Patanjali Foods
    352.00 613.95(%)
  • Netweb Technol.
    4,490.00 5,810.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Indoco Remedies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 12579.0
  • ISIN : INE873D01024
220.65 1 (0.52%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    216.50

  • Today’s High

    237.10

  • Open

    219.00

  • Perv Close

    219.50

  • 52W Low

    162.19

  • 52W High

    288.00

Key Indicators

  • P/E(TTM)

    253.62

  • Mar.Cap (₹Cr.)

    2,036.68

  • Div & Yield %

    0.09

  • Book Value(₹)

    131.06

  • Debt-Equity Ratio

    0.52

  • AGM Date

    27-Oct-2026

  • EPS

    0.87

  • P/E Ratio

    253.62

Financials Ratios

  • Debt-Equity Ratio

    0.47

  • Mar.Cap (₹Cr.)

    2,036.68

  • RONW (%)

    9.07

  • ROCE (%)

    10.76

Score Board

  • Equity (₹ in Cr.)

    18.46

  • BV (₹)

    131.10

  • Sales( ₹ in Cr.)

    1,686.07

  • NP (in Cr.)

    -3.05

  • NP Var(%)

    70.0

  • Div%

    10.0

  • CPS (₹)

    11.30

  • EPS (₹)

    -0.30

  • Traded Value (₹ in Lakhs)

    2,036.68

  • 52 Week High

    288.00

  • 52 Week Low

    162.19

  • Price BSE

    221.0

  • Price NSE

    221.00

  • Market Capital( in Cr.)

    2,036.68

  • P/C Ratio

    19.60

  • P/E Ratio

    -667.90

  • Price Vs.BV

    -0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 1,686.07 1,518.19 1,790.81 1,666.69 1,539.72 1,240.30
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,686.07 1,518.19 1,790.81 1,666.69 1,539.72 1,240.30
Other Income 33.10 19.48 28.24 2.33 2.32 3.11
Stock Adjustments -7.20 32.04 14.70 -6.55 26.30 12.13
Total Income 1,711.97 1,569.71 1,833.75 1,662.47 1,568.34 1,255.54
EXPENDITURE :            
Raw Materials 493.35 475.72 561.15 514.74 483.05 366.20
Power and Fuel Cost 55.44 53.45 55.31 50.61 42.78 36.89
Employee Cost 393.63 368.74 350.55 321.15 294.95 272.88
Other Manufacturing Expenses 104.33 91.60 116.72 89.70 60.66 46.07
Selling and Administration Expenses 387.62 387.49 407.12 340.26 293.42 258.53
Miscellaneous Expenses 93.66 45.19 64.86 58.79 64.15 48.29
Employee Benefit Expenses 393.63 368.74 350.55 321.15 294.95 272.88
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,528.03 1,422.19 1,555.72 1,375.25 1,239.02 1,028.86
Operating Profit 183.95 147.50 278.02 287.22 329.32 226.69
Interest 88.50 56.63 36.81 25.03 14.14 22.22
Gross Profit 95.45 90.87 241.21 262.19 315.18 204.47
Depreciation 106.90 98.25 87.98 70.60 78.95 73.12
Profit Before Tax -11.45 -7.38 153.23 191.59 236.23 131.35
Current Tax 2.92 0.00 32.77 55.20 93.23 38.47
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -8.73 1.36 3.81 -4.97 -11.52 0.48
Reported Net Profit -5.63 -8.74 116.64 141.36 154.52 92.39
Extraordinary Items -2.58 1.36 8.49 -0.90 -0.31 -0.17
Adjusted Net Profit -3.05 -10.10 108.15 142.26 154.83 92.56
Adjustment below Net Profit 1.33 -4.49 0.04 1.44 -5.33 -0.86
P & L Balance brought forward 754.44 781.49 685.55 563.48 428.11 339.35
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.85 13.83 20.73 20.73 13.82 2.76
P & L Balance carried down 748.29 754.44 781.49 685.55 563.48 428.11
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 75.00 112.50 112.50 75.00
Dividend Per Share(Rs) 0.20 0.20 1.50 2.25 2.25 1.50
Earnings Per Share-Unit Curr -0.61 -0.95 12.65 15.34 16.77 10.03
Earnings Per Share(Adj)-Unit Curr -0.61 -0.95 12.65 15.34 16.77 10.03
Book Value 119.08 119.61 122.22 111.45 98.13 83.44
Book Value(Adj)-Unit Curr 119.08 119.61 122.22 111.45 98.13 83.44

Shareholding Pattern

  • Promoter Group

    58.92%

  • Public Share Holding

    40.94%

  • Custodian

    0.14%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 15,858,805 17.18 15,858,805 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 20,113,097 21.79 20,113,097 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 18,414,277 19.95 18,414,277 6
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 54,386,179 58.92 54,386,179 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,515,773 1.64 1,515,773 40
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 15,174,532 16.44 15,174,532 7
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 182,690 0.20 182,690 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 16,872,995 18.28 16,872,995 51
2] Non Institution
Bodies Corporate 2,714,827 2.94 2,714,827 190
Clearing Members 35,183 0.04 35,183 19
Directors of their Relatives 1,140,500 1.24 1,140,500 6
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 609,282 0.66 609,282 851
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 490,423 0.53 490,423 705
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,521,364 4.90 4,521,364 19
Individuals holding nominal share capital up to Rs. 1 lakh 11,118,198 12.05 10,885,998 32,223
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 150,349 0.16 150,349 1
Sub Total 20,914,531 22.66 20,682,331 34,033
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 129,900 0.14 129,900 1
Total Shares held by Custodians and against which Depository Receipts have been issued 129,900 0.14 129,900 1
Grand Total ( A + B + C ) 92,303,605 100.00 92,071,405 34,098

Company Background

Indoco Remedies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Indoco Remedies Ltd
  • BSE Code : 12579.0
  • ISIN : INE873D01024

  • Incorporation Year

    1947

  • Registered Office

    Indoco House 166 C S T Road
    Santacruz (East) Kalina, Mumbai,
    Maharashtra-400098

  • Telephone

    91-022-26541851-55

  • FAX

    91-022-26520787

  • Chairman

    Suresh G Kare

  • Managing Director

    Aditi Kare Panandikar

  • Company Secretary

  • Auditor

    Gokhale & Sathe

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Indoco Remedies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Indoco Remedies 220.65 1,715.71 1,686.07 16.93 4.23
Abbott India 25,488.50 7,217.19 6,929.05 33.54 43.78
Astrazeneca Phar 6,073.10 2,304.07 2,275.58 89.51 27.86
Glaxosmi. Pharma 2,488.75 3,932.76 3,790.20 39.76 58.17
Novartis India 1,847.40 393.10 354.33 46.65 15.94
Cipla 1,350.00 20,102.60 18,979.95 41.15 13.88
Bliss GVS Pharma 643.55 773.53 729.81 59.81 12.51
Amrutanjan Healt 490.45 520.13 502.55 26.27 24.16
Fermenta Biotec. 449.00 474.15 450.25 20.96 18.77
Guj. Themis Bio. 352.45 168.25 165.82 94.24 18.05
Ambalal Sarabhai 35.40 19.52 3.94 65.56 6.77